Literature DB >> 18358258

Dietary supplements in the management of diabetes: potential risks and benefits.

Patti Geil1, Laura Shane-McWhorter.   

Abstract

A wide range of products claiming to lower blood glucose levels or prevent and treat diabetes complications and comorbidities are marketed to the public. Yet many individuals with diabetes are reluctant to inform their health care providers of complementary therapy use. As the nutrition experts on diabetes care teams, registered dietitians, in conjunction with pharmacists, are uniquely positioned to encourage patients to communicate openly about their use of dietary supplements, provide safety and efficacy information about supplements, and discourage use of dangerous or ineffective products. Areas of concern with dietary supplement use include potential side effects, drug interactions, and lack of product standardization, in addition to the increased costs that patients may incur when they use ineffective therapies or delay treatment with proven therapeutic agents. The science behind dietary supplements is evolving and registered dietitians must fully understand the potential risks and benefits to advise their patients appropriately, yet respect their health care values and beliefs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358258     DOI: 10.1016/j.jada.2008.01.020

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  9 in total

Review 1.  Outpatient Management of Pediatric Type 1 Diabetes.

Authors:  Joni K Beck; Fran R Cogen
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Sep-Oct

Review 2.  A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS).

Authors:  Arezoo Moini Jazani; Hamidreza Nasimi Doost Azgomi; Alireza Nasimi Doost Azgomi; Ramin Nasimi Doost Azgomi
Journal:  Daru       Date:  2019-11-18       Impact factor: 3.117

3.  Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey.

Authors:  Richard L Nahin; Danita Byrd-Clark; Barbara J Stussman; Nilesh Kalyanaraman
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

4.  Evaluation of Fenugreek (Trigonella foenum-graceum L.), Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome.

Authors:  Maryam Hassanzadeh Bashtian; Seyed Ahmad Emami; Nezhat Mousavifar; Habib Allah Esmaily; Mahmoud Mahmoudi; Amir Hooshang Mohammad Poor
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

5.  Preclinical Toxicological Evaluation of IDM01: The Botanical Composition of 4-Hydroxyisoleucine- and Trigonelline-based Standardized Fenugreek Seed Extract.

Authors:  Pallavi O Deshpande; Vishwaraman Mohan; Prasad Arvind Thakurdesai
Journal:  Pharmacognosy Res       Date:  2017 Apr-Jun

Review 6.  Unproven Therapies for Diabetes and Their Implications.

Authors:  Jothydev Kesavadev; Banshi Saboo; Shaukat Sadikot; Ashok Kumar Das; Shashank Joshi; Rajeev Chawla; Hemant Thacker; Arun Shankar; Lakshmy Ramachandran; Sanjay Kalra
Journal:  Adv Ther       Date:  2016-11-18       Impact factor: 3.845

7.  Use of Food Supplements in Diabetes Mellitus Treatment in Bosnia and Herzegovina from the Pharmacists Perspective.

Authors:  Tarik Catic; Rasim Jusufovic
Journal:  Mater Sociomed       Date:  2019-06

8.  Potential Therapeutic Effects of Curcumin on Glycemic and Lipid Profile in Uncomplicated Type 2 Diabetes-A Meta-Analysis of Randomized Controlled Trial.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Ciro Marziliano; Marianna Mastrodomenico; Anna Rita Giuliani; Reimondo Petrocelli
Journal:  Nutrients       Date:  2021-01-27       Impact factor: 5.717

Review 9.  Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.

Authors:  Yoon Sin Oh
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.